Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial ...
Smithfield Foods, Inc. (the "Company"), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced ...